Labiotech.eu

News and Trends 27 Jun 2022

Saudi Arabia to inject $3B into vaccines and medicines industry

Saudi Arabia is boosting biotech and looking to become a center for the vaccine industry. The Saudi Arabian Minister of Industry and Mineral Resources, chairman of the manufacturing vaccines and vital medicines committee, Bandar bin Ibrahim Alkhorayef, has announced the launch of several investment opportunities in the vaccines and vital medicines industry, valued at $3.4 […]

June 27, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 27 Jun 2022

Trial for adults with late onset Pompe disease halted due to serious adverse event

The US Food and Drug Administration (FDA) has placed a clinical hold on a trial being run for Astrellas Pharma Inc after one of the participants had a serious adverse event (SAE) of peripheral sensory neuropathy. Astrellas made the announcement after the trial, which is evaluating AT845, an investigational adeno-associated virus (AAV) gene replacement in […]

June 27, 2022 - 3 minutesmins - By Liza Laws

News and Trends 27 Jun 2022

Covid vaccine granted marketing authorization in Europe

Specialty vaccine company, Valneva, has been given marketing authorization in Europe for its inactivated whole-virus COVID-19 vaccine VLA2001. This is a turnaround from the company’s situation in May of this year when the stock price was knocked down by 20% when gaining traction in the EU was proving to be a struggle. Despite authorization from […]

June 27, 2022 - 3 minutesmins - By Liza Laws

News and Trends 27 Jun 2022

Fermentation facility opens its doors in Wisconsin

A new fermentation facility producing food ingredients and cultures, bacterial cultures, and probiotics has been opened in Franksville, Wisc., by Cultures Supporting Life (CSL). The ingredients, cultures and probiotics produced will be used in dairy, food, dietary supplements, pharma, and agriculture. Kyle Griffiths, vice president of sales and marketing said: “The new production facilities located […]

June 27, 2022 - 2 minutesmins - By Liza Laws

North america sequencing ultima genomics biotech investment

In Depth 27 Jun 2022

The biggest US biotech investments in May 2022

The DNA sequencing newcomer Ultima Genomics won the crown for the biggest U.S private biotech investment in May 2022. Other top fundraising firms are developing gene and cell therapies in addition to cultured leather and omics-based diagnostics. The headliner private biotech investment in the US in May 2022 went to the Californian firm Ultima Genomics. […]

June 27, 2022 - 3 minutesmins - By Jonathan Smith

More News! 24 Jun 2022

Gurnet Point Capital and Patient Square Capital buy Radius Health for $890M

Global pharmaceutical company, Radius Health Inc, announced this week (June 23) that it has entered into a definitive agreement to be bought out by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately $890 million. Radius Health is a company focused on addressing unmet medical needs in the areas of bone […]

June 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 24 Jun 2022

Stramsen Biotech to look at 11 plant-based drug candidates

Houston-based biotechnology firm Stramsen Biotech Inc. has announced 11 drug candidates for clinical development. Kefas Mugittu, co-CEO, made the announcement of the plant-based medical candidates. The company said the drugs are safe, effective and currently in use in different countries. The drug candidates are: SBX 1052, which controls/prevents enlargement of the prostate glands; SBX1968, which […]

June 24, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 24 Jun 2022

Study reveals progress for those with hepatitis B

A clinical-stage biopharma company has announced its study of product VTP-300 for use in patients with hepatitis B has resulted in positive safety and efficacy data. Vaccitech plc deals with novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases, cancer, and autoimmune diseases. The updated analysis includes 39 patients with at least […]

June 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 24 Jun 2022

Covid and malaria vaccines on track for mass production in Rwanda

Construction of the first African messenger RNA (mRNA) manufacturing facility has started in Africa. This means Biopharmaceutical New Technologies (BioNTech) SE is a step closer to producing mRNA vaccines that teach human cells how to make a protein that will trigger an immune response inside the body. The company is a next generation immunotherapy company […]

June 24, 2022 - 3 minutesmins - By Liza Laws

News and Trends 24 Jun 2022

Second dairy cellular agtech incubator program Mylkcubator opens

Pascual, a Spanish manufacturer of dairy products and beverages, has launched Mylkcubator 2.0, the second edition of its global incubation program for cellular agriculture technologies in the dairy industry. The initiative has been launched from the group’s Corporate Venture unit, Pascual Innoventures, in collaboration with Eatable Adventures, a global foodtech accelerator. Mylkcubator 2.0 will last […]

June 24, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 24 Jun 2022

Beyond Biotech podcast 2: Asabys, Asebio, MOA Foodtech

This week’s podcast is dedicated to Spain. We have conversations with bioindustry association AseBio’s CEO, Ion Arocena; Clara Campàs, managing partner and co-founder of venture capital company Asabys, and Susana Sánchez Gómez, co-founder and chief scientific officer at MOA Foodtech. AseBio, the Spanish Bioindustry Association, brings together and represents the interests of companies, associations, foundations, […]

June 24, 2022

News and Trends 23 Jun 2022

Evaxion Biotech picks candidate for lung cancer trial

A clinical-stage biotech company that specializes in developing AI-driven immunotherapies has chosen its product candidate for an upcoming clinical trial for patients with advanced lung cancer. Evaxion Biotech selected EVX-03 within its DNA technology platform to target a new indication based on what it said are very encouraging results from pre-clinical studies. EVX-03 is optimized […]

June 23, 2022 - 2 minutesmins - By Liza Laws

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Saudi Arabia to inject $3B into vaccines and medicines industry

Trial for adults with late onset Pompe disease halted due to serious adverse event

Covid vaccine granted marketing authorization in Europe

Fermentation facility opens its doors in Wisconsin

The biggest US biotech investments in May 2022

Gurnet Point Capital and Patient Square Capital buy Radius Health for $890M

Stramsen Biotech to look at 11 plant-based drug candidates

Study reveals progress for those with hepatitis B

Covid and malaria vaccines on track for mass production in Rwanda

Second dairy cellular agtech incubator program Mylkcubator opens

Beyond Biotech podcast 2: Asabys, Asebio, MOA Foodtech

Evaxion Biotech picks candidate for lung cancer trial

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!